Cosentino, G.; Zaffina, C.; Zoccola, C.; Fresia, M.; Merli, S.; Mauramati, S.; Bertino, G.; Todisco, M.; Dodge, S.; Barmada, S.;
et al. Unilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study. Toxins 2025, 17, 458.
https://doi.org/10.3390/toxins17090458
AMA Style
Cosentino G, Zaffina C, Zoccola C, Fresia M, Merli S, Mauramati S, Bertino G, Todisco M, Dodge S, Barmada S,
et al. Unilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study. Toxins. 2025; 17(9):458.
https://doi.org/10.3390/toxins17090458
Chicago/Turabian Style
Cosentino, Giuseppe, Chiara Zaffina, Clara Zoccola, Mauro Fresia, Sara Merli, Simone Mauramati, Giulia Bertino, Massimiliano Todisco, Shayan Dodge, Sami Barmada,
and et al. 2025. "Unilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study" Toxins 17, no. 9: 458.
https://doi.org/10.3390/toxins17090458
APA Style
Cosentino, G., Zaffina, C., Zoccola, C., Fresia, M., Merli, S., Mauramati, S., Bertino, G., Todisco, M., Dodge, S., Barmada, S., Alfonsi, E., & Tassorelli, C.
(2025). Unilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study. Toxins, 17(9), 458.
https://doi.org/10.3390/toxins17090458
